CN106616139A - Children's functional drink - Google Patents
Children's functional drink Download PDFInfo
- Publication number
- CN106616139A CN106616139A CN201610788381.3A CN201610788381A CN106616139A CN 106616139 A CN106616139 A CN 106616139A CN 201610788381 A CN201610788381 A CN 201610788381A CN 106616139 A CN106616139 A CN 106616139A
- Authority
- CN
- China
- Prior art keywords
- enzymolysis
- children
- active component
- product
- enzyme
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 47
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 claims abstract description 10
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 claims abstract description 10
- 235000021552 granulated sugar Nutrition 0.000 claims abstract description 10
- 239000000047 product Substances 0.000 claims description 53
- 108090000790 Enzymes Proteins 0.000 claims description 36
- 102000004190 Enzymes Human genes 0.000 claims description 36
- 229940088598 enzyme Drugs 0.000 claims description 36
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 24
- 241001339782 Scapharca broughtonii Species 0.000 claims description 21
- 239000007788 liquid Substances 0.000 claims description 21
- 241001454694 Clupeiformes Species 0.000 claims description 20
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 20
- 235000019513 anchovy Nutrition 0.000 claims description 20
- 102000057297 Pepsin A Human genes 0.000 claims description 18
- 108090000284 Pepsin A Proteins 0.000 claims description 18
- 229940111202 pepsin Drugs 0.000 claims description 18
- 238000002360 preparation method Methods 0.000 claims description 18
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 claims description 13
- 210000002784 stomach Anatomy 0.000 claims description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
- 239000000287 crude extract Substances 0.000 claims description 12
- 108090000317 Chymotrypsin Proteins 0.000 claims description 10
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 10
- 239000002253 acid Substances 0.000 claims description 10
- 239000003513 alkali Substances 0.000 claims description 10
- 238000009835 boiling Methods 0.000 claims description 10
- 229960002376 chymotrypsin Drugs 0.000 claims description 10
- 238000001035 drying Methods 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 10
- 239000000758 substrate Substances 0.000 claims description 10
- 241000894006 Bacteria Species 0.000 claims description 9
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 9
- 230000007062 hydrolysis Effects 0.000 claims description 9
- 238000006460 hydrolysis reaction Methods 0.000 claims description 9
- 239000001509 sodium citrate Substances 0.000 claims description 9
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 9
- 239000001488 sodium phosphate Substances 0.000 claims description 9
- 229910000162 sodium phosphate Inorganic materials 0.000 claims description 9
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 claims description 9
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 8
- 239000001963 growth medium Substances 0.000 claims description 8
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 8
- 239000000811 xylitol Substances 0.000 claims description 8
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 8
- 229960002675 xylitol Drugs 0.000 claims description 8
- 235000010447 xylitol Nutrition 0.000 claims description 8
- 210000001835 viscera Anatomy 0.000 claims description 7
- 241001499733 Plantago asiatica Species 0.000 claims description 6
- 241000196324 Embryophyta Species 0.000 claims description 5
- 238000000855 fermentation Methods 0.000 claims description 5
- 230000004151 fermentation Effects 0.000 claims description 5
- 235000013372 meat Nutrition 0.000 claims description 5
- 239000001103 potassium chloride Substances 0.000 claims description 5
- 235000011164 potassium chloride Nutrition 0.000 claims description 5
- 241000233866 Fungi Species 0.000 claims description 3
- 229920001503 Glucan Polymers 0.000 claims description 3
- 239000000706 filtrate Substances 0.000 claims description 3
- 239000012535 impurity Substances 0.000 claims description 3
- 239000012074 organic phase Substances 0.000 claims description 3
- 239000012071 phase Substances 0.000 claims description 3
- 238000010992 reflux Methods 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims description 3
- 238000009777 vacuum freeze-drying Methods 0.000 claims description 3
- 238000001694 spray drying Methods 0.000 claims description 2
- 244000241257 Cucumis melo Species 0.000 claims 2
- 235000013601 eggs Nutrition 0.000 claims 2
- 108091005804 Peptidases Proteins 0.000 claims 1
- 239000004365 Protease Substances 0.000 claims 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims 1
- 241000219112 Cucumis Species 0.000 abstract description 8
- 230000036039 immunity Effects 0.000 abstract description 4
- 230000012010 growth Effects 0.000 abstract description 3
- 201000010099 disease Diseases 0.000 abstract description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 2
- 230000007661 gastrointestinal function Effects 0.000 abstract description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 210000004204 blood vessel Anatomy 0.000 abstract 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 abstract 1
- 229910000397 disodium phosphate Inorganic materials 0.000 abstract 1
- 235000019800 disodium phosphate Nutrition 0.000 abstract 1
- 239000008103 glucose Substances 0.000 abstract 1
- 230000008821 health effect Effects 0.000 abstract 1
- 229940088592 immunologic factor Drugs 0.000 abstract 1
- 239000000367 immunologic factor Substances 0.000 abstract 1
- 235000013336 milk Nutrition 0.000 abstract 1
- 239000008267 milk Substances 0.000 abstract 1
- 210000004080 milk Anatomy 0.000 abstract 1
- 235000016709 nutrition Nutrition 0.000 abstract 1
- 230000035764 nutrition Effects 0.000 abstract 1
- 239000013589 supplement Substances 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 19
- 241000699666 Mus <mouse, genus> Species 0.000 description 18
- 238000012360 testing method Methods 0.000 description 17
- 210000004027 cell Anatomy 0.000 description 13
- 239000013642 negative control Substances 0.000 description 13
- 230000000694 effects Effects 0.000 description 10
- 230000037396 body weight Effects 0.000 description 9
- 239000013641 positive control Substances 0.000 description 9
- 210000002966 serum Anatomy 0.000 description 8
- 238000007619 statistical method Methods 0.000 description 8
- 241000700159 Rattus Species 0.000 description 7
- 238000004458 analytical method Methods 0.000 description 7
- 210000004698 lymphocyte Anatomy 0.000 description 7
- 235000015097 nutrients Nutrition 0.000 description 7
- 239000012980 RPMI-1640 medium Substances 0.000 description 6
- 210000000952 spleen Anatomy 0.000 description 6
- 210000004988 splenocyte Anatomy 0.000 description 6
- 239000000725 suspension Substances 0.000 description 6
- 238000003304 gavage Methods 0.000 description 5
- 210000003128 head Anatomy 0.000 description 5
- 238000002347 injection Methods 0.000 description 5
- 239000007924 injection Substances 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 4
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 4
- 238000005119 centrifugation Methods 0.000 description 4
- 238000005660 chlorination reaction Methods 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 239000011591 potassium Substances 0.000 description 4
- 229910052700 potassium Inorganic materials 0.000 description 4
- 230000009182 swimming Effects 0.000 description 4
- 229920000936 Agarose Polymers 0.000 description 3
- 108010006464 Hemolysin Proteins Proteins 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 235000013361 beverage Nutrition 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 238000010241 blood sampling Methods 0.000 description 3
- 239000007853 buffer solution Substances 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 239000003228 hemolysin Substances 0.000 description 3
- 239000000976 ink Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 230000000242 pagocytic effect Effects 0.000 description 3
- 239000002504 physiological saline solution Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 238000011725 BALB/c mouse Methods 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 206010018910 Haemolysis Diseases 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 241001494479 Pecora Species 0.000 description 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000002929 anti-fatigue Effects 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 150000005693 branched-chain amino acids Chemical class 0.000 description 2
- 239000012267 brine Substances 0.000 description 2
- 210000005252 bulbus oculi Anatomy 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 238000004043 dyeing Methods 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 238000005534 hematocrit Methods 0.000 description 2
- 230000008588 hemolysis Effects 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 229960000310 isoleucine Drugs 0.000 description 2
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 2
- JKQOBWVOAYFWKG-UHFFFAOYSA-N molybdenum trioxide Chemical compound O=[Mo](=O)=O JKQOBWVOAYFWKG-UHFFFAOYSA-N 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Substances [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- KKCBUQHMOMHUOY-UHFFFAOYSA-N sodium oxide Chemical compound [O-2].[Na+].[Na+] KKCBUQHMOMHUOY-UHFFFAOYSA-N 0.000 description 2
- 229910001948 sodium oxide Inorganic materials 0.000 description 2
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 2
- 230000008719 thickening Effects 0.000 description 2
- 210000001541 thymus gland Anatomy 0.000 description 2
- 239000004474 valine Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- NPUHEVDUAJADGU-UHFFFAOYSA-N N-[1-(hydroxyamino)ethylideneamino]acetamide Chemical compound C(C)(=O)NNC(C)=NO NPUHEVDUAJADGU-UHFFFAOYSA-N 0.000 description 1
- 241000233805 Phoenix Species 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 239000011260 aqueous acid Substances 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 229960004424 carbon dioxide Drugs 0.000 description 1
- 229910002090 carbon oxide Inorganic materials 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000012636 effector Substances 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000019688 fish Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 244000005709 gut microbiome Species 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000008944 intestinal immunity Effects 0.000 description 1
- 238000009533 lab test Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 235000020124 milk-based beverage Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 230000007659 motor function Effects 0.000 description 1
- 230000021332 multicellular organism growth Effects 0.000 description 1
- 210000000822 natural killer cell Anatomy 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000000384 rearing effect Effects 0.000 description 1
- 239000013558 reference substance Substances 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/70—Clarifying or fining of non-alcoholic beverages; Removing unwanted matter
- A23L2/84—Clarifying or fining of non-alcoholic beverages; Removing unwanted matter using microorganisms or biological material, e.g. enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention provides children's functional drink. According to a technical scheme of the invention, the children's functional drink is prepared from, by weight, 10-30 parts of white granulated sugar, 11-15 parts of active component B, 9-13 parts of active ingredient, 2-6 parts of sodium hydrogen phosphate, 0.3-0.5 part of Hami melon essence, 3-5 parts of glucose, and 105-135 parts of water. The children's functional drink has rich nutrition and good taste, contains immune factors required by human bodies, can promote the growth and development of bodies, adjust gastrointestinal function, improve bodily immunity, refresh milk and enhance fatigue resistance, has significant health effect for the diseases such as heart, blood vessels and cervical vertebra; the children's functional drink is suitable for general people, especially children, and can significantly improve the growth and development of children and supplement energy.
Description
Technical field
The invention belongs to medicines and health protection field, and in particular to a kind of children's drinks.
Background technology
At present, children's beverage great majority on the market do not possess health care, and some sodas drink for a long time meeting
Many negative impacts are caused to the healthy of children.And such as calcium milk drink, also mainly supplementing calcium activated and vitamin
A, C, D etc. are main purpose, and its action effect is single, and assimilation effect is slow, and real meaning is not also belonged to a certain extent
Heath-function beverage.
The content of the invention
In view of this, the present invention provides a kind of children's drinks, and the drinks of the present invention are nutritious, in good taste,
Immune-regulating factor rich in needed by human body, can promote body growth to develop, and adjust gastrointestinal function, improve immunity of organisms, carry
Refreshing restoring consciouness, strengthens anti-fatigue ability, has obvious health-care effect to diseases such as the heart, the cerebrovascular and cervical vertebras.The present invention is adapted to vast
Crowd is particularly children and drinks, and to children's growth, supplementary physical efficiency significant facilitation is played.
The technical scheme is that:A kind of children's drinks, it is in parts by weight, composed of the following components:Activearm
Divide A 40-50, potassium chloride 1-3, xylitol 5-8, sodium citrate 2-4, white granulated sugar 10-30, active component B 11-15, activearm
Divide C 9-13, dibastic sodium phosphate 2-6, Hami melon essence 0.3-0.5, glucan 3-5, water 105-135.
Further, described children, it is in parts by weight, composed of the following components:Active component A 43, potassium chloride 2, wood
Sugar alcohol 6, sodium citrate 3, white granulated sugar 14, active component B 13, active component C 11, dibastic sodium phosphate 4, Hami melon essence 0.4,
Bextran 45, water 118.
Further, the active component A be long tail anchovy enzymolysis product, the preparation method of the long tail anchovy enzymolysis product
For:S1. long tail anchovy minced fillet is taken, makes material-water ratio be 1:2-1:8 (w/v), 2.0-3.5 is adjusted to 2 mol/L hydrochloric acid by solution ph
So that stomach acid or alkali environment is presented, pepsin is added by 1200-1500U/g of enzyme-to-substrate concentration ratio, in water bath with thermostatic control vibration
37 DEG C of holding, 100-130 r/min vibration enzymolysis 1.5-2.5 h, obtain with this understanding the first of Jing pepsins enzymolysis in device
Product;S2. the enzymolysis liquid pH value Jing after pepsin enzymolysis is adjusted into 8.0-9.0 with the NaOH of 2 mol/L, keeps 37
DEG C hydrolysis temperature, complex enzyme addition is 4500-6000 U/g, trypsase and chymotrypsin in the complex enzyme
Mass ratio is 4:1-6:1, the material-water ratio 1:3-1:6, enzymolysis time is 3-4.5 h, after enzymolysis terminates, in 100 DEG C of boiling water baths
In go out enzyme 10min;By the enzymolysis product in S2 by vacuum freeze drying, settings drying condition is -30 DEG C of precooling temperature, precooling
Time 2h, heating-up temperature starts slowly to be heated up after 18h from -10 DEG C, reaches 25 DEG C, and remains to and be dried terminal, obtains long tail anchovy
Enzymolysis product.
Further, the active component A be long tail anchovy enzymolysis product, the preparation method of the long tail anchovy enzymolysis product
For:S1. long tail anchovy minced fillet is taken, makes material-water ratio be 1:3 (w/v), solution ph with 2 mol/L hydrochloric acid be adjusted to 2.5 stomach is presented
Portion's acid or alkali environment, by 1300 U/g of enzyme-to-substrate concentration ratio pepsin is added, and 37 are kept in thermostatic control oscillator vibration
DEG C, 110 r/min vibration 2 h of enzymolysis, the head product of Jing pepsins enzymolysis is obtained with this understanding;S2. with the hydrogen of 2 mol/L
Enzymolysis liquid pH value Jing after pepsin enzymolysis is adjusted to 8.5 by sodium oxide molybdena, keeps the 37 DEG C of hydrolysis temperatures, complex enzyme addition to be
5200 U/g, trypsase and the mass ratio of chymotrypsin are 5 in the complex enzyme:1, the material-water ratio 1:4.5, enzyme
The solution time is 3.5 h, and after enzymolysis terminates, go out enzyme 10min in 100 DEG C of boiling water baths;Enzymolysis product in S2 is cold by vacuum
Lyophilized dry, setting drying condition is -30 DEG C of precooling temperature, and pre-coo time 2h, heating-up temperature starts slowly to be risen after 18h from -10 DEG C
Temperature, reaches 25 DEG C, and remains to and be dried terminal, obtains long tail anchovy enzymolysis product.
Further, active component B is mud blood clam enzymolysis product, and the preparation method of the mud blood clam enzymolysis product is:S1.
Take mud blood clam whole viscera and blend into meat gruel, make material-water ratio be 1:1-1:2 (w/v), 2.0 are adjusted to 2 mol/L hydrochloric acid by solution ph
So that stomach acid or alkali environment is presented, pepsin is added by 800-1000U/g of enzyme-to-substrate concentration ratio, in thermostatic control oscillator vibration
It is middle to keep 37 DEG C, 75-105 r/min vibration enzymolysis 1-1.5 h, the head product of Jing pepsins enzymolysis is obtained with this understanding;
S2. the enzymolysis liquid pH value Jing after pepsin enzymolysis is adjusted into 8.0-9.0 with the NaOH of 2 mol/L, keeps 37 DEG C of enzymolysis
Temperature, complex enzyme addition is 2500-3500 U/g, the mass ratio of trypsase and chymotrypsin in the complex enzyme
For 6:1-8:1, the material-water ratio 1:2-1:4, enzymolysis time is 2.5-3.5 h, after enzymolysis terminates, is gone out in 100 DEG C of boiling water baths
Enzyme 10min;By the enzymolysis product in S2 by way of being spray-dried, setting drying condition is 160 DEG C of EAT, and sample introduction is fast
Spend for 50ml/min, centrifugal atomizer rotating speed is 25000r/min, obtains mud blood clam enzymolysis product.
Further, active component B is mud blood clam enzymolysis product, and the preparation method of the mud blood clam enzymolysis product is:
S1. take mud blood clam whole viscera and blend into meat gruel, make material-water ratio be 1:1.5 (w/v), 2.0 are adjusted to 2 mol/L hydrochloric acid by solution ph
So that stomach acid or alkali environment is presented, pepsin is added by 880U/g of enzyme-to-substrate concentration ratio, protected in thermostatic control oscillator vibration
37 DEG C, 85 r/min vibration 1.3 h of enzymolysis are held, the head product of Jing pepsins enzymolysis is obtained with this understanding;S2. with 2
Enzymolysis liquid pH value Jing after pepsin enzymolysis is adjusted to 8.2 by the NaOH of mol/L, keeps 37 DEG C of hydrolysis temperatures, complex enzyme
Addition is 2900 U/g, and trypsase and the mass ratio of chymotrypsin are 7 in the complex enzyme:1, the material-water ratio
1:2.5, enzymolysis time is 2.8 h, and after enzymolysis terminates, go out enzyme 10min in 100 DEG C of boiling water baths;Enzymolysis product in S2 is led to
The mode being spray-dried is crossed, setting drying condition is 160 DEG C of EAT, and sample introduction speed is 50ml/min, and centrifugal atomizer turns
Speed is 25000r/min, obtains mud blood clam enzymolysis product.
Further, active component C be Asiatic plantain thalline crude extract, the preparation side of the Asiatic plantain thalline crude extract
Method is:Root, stem, the leaf for taking fresh plant is cleaned respectively to without obvious impurity, after surface sterilization is processed, is seeded to PDA
(Separate endogenetic fungus)With Gause I culture medium(Separate endogeny rayungus)Upper culture 5-7 d, are then peeled off obtaining bacterium colony;
Picking inoculated by hypha block puts 30 DEG C, 150 r/ in the conical flask equipped with 100 mL fermentation mediums from activated inclined plane
The d of min shaking tables shaken cultivation 3;Fermentation culture medium removes thalline, and filtrate is extracted 3 times with equal-volume ethyl acetate, is merged organic
Phase, 45 DEG C of reduced pressure concentrations are evaporated, as mixed bacteria liquid crude extract;Centrifugation and the thalline being filtrated to get, with appropriate 95% ethanol
Condensing reflux 3 times, merges ethanol phase, and reduced pressure concentration is evaporated, as thalline crude extract.
In above-mentioned technical proposal, the preparation method of described motor function beverage is:By proportioning, each component is mixed, stirred
Finished product is obtained by mixing after being uniformly dispersed.
Raw material of the present invention are easy to buying, make simple;And rich in rich in protein, vitamin and mineral matter;Just
In carrying, conveniently drink, quickly eliminate hunger, mouthfeel is soft, taste is unique;Especially suitable drinking of children.Experience of the present invention
Card, drinks for a long time the effect that can reach strengthen immunity and whitening, based on main active component in the present invention using simulation human body
The mode of gastro-intestinal digestion is obtained, and coordinates the active drive member extracted from plant body, active drive member to enter in enteron aisle,
On the one hand can colonize in enteron aisle, maintain the balance of intestinal microflora;On the other hand it is active drive member and phoenix tail
Fish enzymolysis product and mud blood clam enzymolysis product collective effect induce intestine immunity in the immune system of host, and stimulate thymus gland, spleen
It is dirty to wait immune organ, promote macrophage activity, by strengthening reactivity of B, T lymphocyte to antigenic stimulus, play special
Property immunocompetence, so as to strengthen the immunologic function of body, it is easy to be absorbed by the body, the low age crowd long-term taking of condition 98% is invariably
Suitable symptom.
Specific embodiment
Below in conjunction with specific embodiment, the invention will be further described.
Embodiment 1
A kind of children's drinks, it is in parts by weight, composed of the following components:Active component A 43, potassium chloride 2, xylitol 6,
Sodium citrate 3, white granulated sugar 14, active component B 13, active component C 11, dibastic sodium phosphate 4, Hami melon essence 0.4, glucan
4, water 118.
Further, the active component A be long tail anchovy enzymolysis product, the preparation method of the long tail anchovy enzymolysis product
For:S1. long tail anchovy minced fillet is taken, makes material-water ratio be 1:3 (w/v), solution ph with 2 mol/L hydrochloric acid be adjusted to 2.5 stomach is presented
Portion's acid or alkali environment, by 1300 U/g of enzyme-to-substrate concentration ratio pepsin is added, and 37 are kept in thermostatic control oscillator vibration
DEG C, 110 r/min vibration 2 h of enzymolysis, the head product of Jing pepsins enzymolysis is obtained with this understanding;S2. with the hydrogen of 2 mol/L
Enzymolysis liquid pH value Jing after pepsin enzymolysis is adjusted to 8.5 by sodium oxide molybdena, keeps the 37 DEG C of hydrolysis temperatures, complex enzyme addition to be
5200 U/g, trypsase and the mass ratio of chymotrypsin are 5 in the complex enzyme:1, the material-water ratio 1:4.5, enzyme
The solution time is 3.5 h, and after enzymolysis terminates, go out enzyme 10min in 100 DEG C of boiling water baths;Enzymolysis product in S2 is cold by vacuum
Lyophilized dry, setting drying condition is -30 DEG C of precooling temperature, and pre-coo time 2h, heating-up temperature starts slowly to be risen after 18h from -10 DEG C
Temperature, reaches 25 DEG C, and remains to and be dried terminal, obtains long tail anchovy enzymolysis product.
Further, active component B is mud blood clam enzymolysis product, and the preparation method of the mud blood clam enzymolysis product is:S1.
Take mud blood clam whole viscera and blend into meat gruel, make material-water ratio be 1:1.5 (w/v), with 2 mol/L hydrochloric acid by solution ph be adjusted to 2.0 with
Stomach acid or alkali environment is presented, by 880U/g of enzyme-to-substrate concentration ratio pepsin is added, kept in thermostatic control oscillator vibration
37 DEG C, 85 r/min vibration 1.3 h of enzymolysis, obtain with this understanding the head product of Jing pepsins enzymolysis;S2. 2 mol/L are used
NaOH the enzymolysis liquid pH value Jing after pepsin enzymolysis is adjusted into 8.2, keep 37 DEG C of hydrolysis temperatures, complex enzyme addition
Measure as 2900 U/g, trypsase and the mass ratio of chymotrypsin are 7 in the complex enzyme:1, the material-water ratio 1:
2.5, enzymolysis time is 2.8 h, and after enzymolysis terminates, go out enzyme 10min in 100 DEG C of boiling water baths;Enzymolysis product in S2 is passed through
The mode of spray drying, setting drying condition be 160 DEG C of EAT, sample introduction speed be 50ml/min, centrifugal atomizer rotating speed
For 25000r/min, mud blood clam enzymolysis product is obtained.
Further, active component C be Asiatic plantain thalline crude extract, the preparation side of the Asiatic plantain thalline crude extract
Method is:Root, stem, the leaf for taking fresh plant is cleaned respectively to without obvious impurity, after surface sterilization is processed, is seeded to PDA
(Separate endogenetic fungus)With Gause I culture medium(Separate endogeny rayungus)Upper culture 5-7 d, are then peeled off obtaining bacterium colony;
Picking inoculated by hypha block puts 30 DEG C, 150 r/ in the conical flask equipped with 100 mL fermentation mediums from activated inclined plane
The d of min shaking tables shaken cultivation 3;Fermentation culture medium removes thalline, and filtrate is extracted 3 times with equal-volume ethyl acetate, is merged organic
Phase, 45 DEG C of reduced pressure concentrations are evaporated, as mixed bacteria liquid crude extract;Centrifugation and the thalline being filtrated to get, with appropriate 95% ethanol
Condensing reflux 3 times, merges ethanol phase, and reduced pressure concentration is evaporated, as thalline crude extract.
Embodiment 2
The present embodiment provides a kind of children's drinks, in parts by weight, composed of the following components:Active component A 40, chlorination
Potassium 2, xylitol 6, sodium citrate 3, white granulated sugar 14, active component B 11, active component C 9, dibastic sodium phosphate 4, Hami melon essence
0.4, bextran 45, water 118.In the present embodiment active component A, active component B, the composition of active component C and preparation method with
Embodiment 1 is consistent.
Embodiment 3
The present embodiment provides a kind of children's drinks, in parts by weight, composed of the following components:Active component A 50, chlorination
Potassium 2, xylitol 6, sodium citrate 3, white granulated sugar 14, active component B 15, active component C 13, dibastic sodium phosphate 4, "Hami" melon is fragrant
Essence 0.4, bextran 45, water 118.Active component A, active component B, the composition of active component C and preparation method in the present embodiment
It is consistent with embodiment 1.
Embodiment 4
The present embodiment provides a kind of children's drinks, in parts by weight, composed of the following components:Active component A 50, chlorination
Potassium 2, xylitol 6, sodium citrate 3, white granulated sugar 14, active component B 15, active component C 9, dibastic sodium phosphate 4, Hami melon essence
0.4, bextran 45, water 118.
Active component A, active component B, the composition of active component C and preparation method are consistent with embodiment 1 in the present embodiment.
Embodiment 5
The present embodiment provides a kind of children's drinks, in parts by weight, composed of the following components:Active component A 40, chlorination
Potassium 2, xylitol 6, sodium citrate 3, white granulated sugar 14, active component B 11, active component C 13, dibastic sodium phosphate 4, "Hami" melon is fragrant
Essence 0.4, bextran 45, water 118.
Active component A, active component B, the composition of active component C and preparation method are consistent with embodiment 1 in the present embodiment.
Effect example
1. strengthen immunity effect experimental
To be dried by drinks thickening obtained in embodiment 1, prepare it is powdered, as test sample.
Reference substance:Its vigorous and graceful board Soybean Peptide albumen powder;Source:Beijing Tongrentang Health Pharmaceutical Co., Ltd.;Adult
Clinic recommends consumption:0.167g.kg-1.d-1。
Animal subject strain and rank:BALB/c mouse, Hartley cavys, SPF levels;Quantity and sex:BALB/c is little
Mouse 60, male;Hartley cavys 6,.Buy body weight BALB/c mouse 17-19g, Hartley cavy 250-
350g.There is provided by Guangdong Medical Lab Animal Center, animal used as test uses credit number:SYXK(Guangdong)2013-0002.Experiment
Period, mouse ad lib drinking-water observes daily mouse state.
Dose design is carried out according to the basic condition of sample, sample is basic, normal, high 5 times by adult's quantity, 10 times,
20 times of design dosage, respectively 0.15g.kg-1.d-1、 0.30g.kg-1.d-1 、0.60g.kg-1.d-1;Positive controls dosage
It is 0.835g.kg by 5 times of designs of adult's recommended dose-1.d-1.60 male mices are respectively divided into at random 5 groups(Negative control
The basic, normal, high dosage group of group, positive controls, given the test agent), 12 per group, wherein 2 are only used as standby animal.Each group mouse is every
It presses 0.1mL/10g body weight gavage respective sample liquid, and negative control group gives equivalent pure water, once a day, successive administration 30
My god.On-test, off-test are weighed in 1 time, are weighed in weekly during test 1 time.
Mouse lymphocyte transformation experiment
Last dose 1h, the aseptic spleen that takes is placed in the culture dish for filling RPMI-1640 nutrient solutions, and places 200 eye mesh screens, with note
Emitter piston grinds above it makes splenocyte suspension, dispenses splenocyte suspension to the centrifuge tube added with lymphocyte separation medium
In.400g, is centrifuged 20min at 20 DEG C, centrifugation is finished, and takes out centrifuge tube medium size lymphocyte layer centrifuge tube, adds RPMI-1640 trainings
Nutrient solution is washed for several times, and 250g is centrifuged 10min at 4 DEG C.After washing is finished, abandoning supernatant adds complete medium, and piping and druming is equal
It is even, expect that blue dyeing counting ensures more than 95% living cell rate with platform, cell concentration is adjusted into 3 × 106Individual/ml.
Every part of splenocyte suspension point holes is added in 48 well culture plates, per hole 0.5ml, a hole adds 25 ul ConA liquid
(Equivalent to 5ug/ml), another hole is placed in 5%CO as control2,37℃CO2Cultivate in incubator after 48h and gently suck supernatant per hole
The ml of liquid 0.3, adds 0.3 mlRPMI-1640 nutrient solutions, while adding the ul/ holes of 8 reagents of CCK 50, continues to cultivate 2 h.Knot
After beam culture, piping and druming is uniform, in being then dispensed into 96 well culture plates, 3 parallel laboratory tests is made per hole, and with ELIASA 450 nm ripples are surveyed
OD value under long.The multiplication capacity of lymphocyte is by the OD value and the OD value for being not added with ConA holes for adding ConA holes
Difference represent.
Mouse humoral immune function(Serum hemolysin)Affect
Administration 25 days, the sheep blood 3 times of fiber has been taken off with brine (2000r/min, 10min), in hematocrit SRBC plus
Enter physiological saline and be made into 2%(v/v)Cell suspension, every mouse peritoneal injection 0.2ml, when the 30th day, administration 1h after, weigh,
All mouse are extractd eyeball and take blood 0.8ml in centrifuge tube, stand 1h, and 2000r/min, 10min is centrifuged, and collect serum.Cervical vertebra takes off
Mortar puts to death mouse.The serum for diluting 300 times with SA buffer solutions takes 1ml and puts in test tube, and 10% is added again(v/v)
SRBC0.5ml, the complement 1ml that 9 times are diluted with SA buffer solutions, arrange control tube(Replace serum with SA), 37 DEG C of waters bath with thermostatic control
20min, then ice bath, are then centrifuged for 2000r/min, 10min.Supernatant 1ml is taken in new test tube, plus 3.75ml Dou Shi reagents,
0.25ml10%(v/v)SRBC, fully mixes, and stands 10min, with control tube as blank, determines each Guan Guangmi at 540nm respectively
Angle value, the amount of hemolysin is with half hemolytic value(HC50)Represent.
Mouse humoral immune(Antibody-producting cell)Impact
Administration 25 days, the sheep blood 3 times of fiber has been taken off with brine, 2000r/min, 10min is centrifuged every time, in hematocrit
Physiological saline is added to be made into 2% in SRBC(v/v)Cell suspension, every mouse peritoneal injection 0.2ml, when the 30th day, be administered 1h
Afterwards, weigh.Cervical dislocation is put to death after mouse, takes out spleen, is placed in and is placed with Hank ' s liquid plates, through 200 mesh sieve net filtrations
Afterwards, then with Hank ' s liquid wash twice, be added in 5mL RPMI-1640 nutrient solutions and cell suspends, count cell, and adjust
Cell concentration is 5 × 106Individual/mL.
After the top layer culture medium heating for dissolving for adding distilled water to be formed to 100mL 1g agaroses, 40-45 DEG C of water bath heat preservation.
Mix with PH7.2-7.4,2 times of Hank ' s liquid equal-volumes, shake up, often pipe 0.5mL dispenses different test tubes, continue to be added to every pipe
With SA buffers into 10%SRBC (v/v)50ul and splenocyte suspension 20ul, it is quick to mix, it is poured into and scribbles one layer
On the thin slice of very thin agarose, parallel plate is done, after agarose solidification, wafer level button is placed on horse, be put into two
After carbonoxide incubator culture 1-1.5h, the complement that 9 times are diluted with SA buffer solutions is added in the groove of glass frame, continues to train
Foster 1-1.5h, then counts hemolysis plaque number.
The measure that mouse monokaryon-macrophage phagocytic function and immune organ affect
Last dose 1h, by body weight from tail vein injection physiological saline 1:The india ink of 3 dilutions(10mL/kg), treat prepared Chinese ink
Injection, immediately timing.2,10min after injection prepared Chinese ink, respectively from orbital venous plexus 20 μ L of blood sampling, and is added to immediately 2mL 0.1%
Na2CO3In solution, with Na2CO3Solution makees blank, and OD value is determined at 600nm wavelength with spectrophotometer(OD),
Calculate phagocytic index a.
Dislocation after mouse blood sampling is put to death, and solution takes liver, spleen and thymus gland, and filter paper is blotted after internal organs peripheral blood, accurate
Weigh, calculate internal organs/body weight ratio.
NK cytoactive detections
Last dose 1h, aseptic to take spleen, the aseptic spleen that takes is placed in the culture dish for filling RPMI-1640 nutrient solutions, and places 200 mesh
Screen cloth, is ground above it with syringe piston and makes splenocyte suspension, and packing splenocyte suspension is to added with separation of lymphocytes
In the centrifuge tube of liquid.400g, is centrifuged 20min at 20 DEG C, centrifugation is finished, and takes out centrifuge tube medium size lymphocyte layer centrifuge tube, adds
RPMI-1640 nutrient solutions are washed for several times, and 250g is centrifuged 10min at 4 DEG C.After washing is finished, abandoning supernatant, addition is trained completely
Foster base, piping and druming is uniform, and with platform blue dyeing counting viable count is expected(Should be more than 95%), finally with the complete culture solutions of RPMI 1640
Adjustment cell concentration is 2 × 107Individual/mL.
In proportion by effector cell and target cell(50:1)Each 100ul adds U-shaped 96 orifice plate;Target cell and nutrient solution are each
100ul adds target cell Spontaneous release hole;Target cell and each 100ul of 0.25%Triton add target cell maximum release aperture.Per group
3 parallel holes are all provided with, 37 DEG C, after 5%CO2 incubator culture 4h, 1500rpm, 5min are centrifuged.Per hole Aspirate supernatant 100ul in
Flat 96 orifice plate, adds LDH matrix liquids 100ul/ hole, reacts 3-10min, adds 1mol/ml HCL 30ul/ holes, enzyme mark
490nm determines OD value.
All data carry out statistical analysis using the softwares of SPSS 16.0, and test result is as shown in the table.
The impact that the embodiment sample of table 1 is converted with control group to mouse lymphocyte
Note:Statistical analysis is carried out using variance analysis method, is compared with negative control group, " a ": p<0.05;With positive controls
Relatively, " b ": p<0.01
The embodiment sample of table 2 is with control group to mouse antibodies level(Serum hemolysin)Impact
Note:Statistical analysis is carried out using variance analysis method, is compared with negative control group, " a ": p<0.05;With positive controls
Relatively, " b ": p<The embodiment sample of 0.01 table 3 and impact of the control group to mouse hemolysis plaque number
Note:Statistical analysis is carried out using variance analysis method, is compared with negative control group, " a ": p<0.05;With positive controls
Relatively, " b ": p<0.01 .
The embodiment sample of table 4 and impact of the control group to mouse phagocytic index
Note:Statistical analysis is carried out using variance analysis method, is compared with negative control group, " a ": p<0.05;With positive controls
Relatively, " b ": p<0.01 .
Impact of the embodiment sample of table 6 with control group to NK cells in mice activity
Note:Statistical analysis is carried out using variance analysis method, is compared with negative control group, " a ": p<0.05;With positive controls
Relatively, " b ": p<0.01 .
Equally, identical experiment is carried out to remaining embodiment and embodiments of the invention remaining proportionings, as a result with embodiment 1
Effect is similar to.
2. antifatigue compliance test result
To be dried by drinks thickening obtained in embodiment 1, prepare it is powdered, as test sample.By physiology
Salt solution is blank control group, with branched-amino aqueous acid as negative control group.
Experimental subjects:From SD rats, provided by Beijing Experimental Animal Center, male and female half and half, 180,220 ± 18g,
At about 3 monthly ages, after laboratory rearing one month, through preliminary swimming instruction blank control group, negative control group are randomly divided into
And sample sets.
Test method
(1) exhausting property of power test:Sample powder is taken, with distillation water dissolves, the concentration of sample is respectively 0.15g.kg-1.d-1、 0.30g.kg-1.d-1 、0.60g.kg-1.d-1 , sample sets press daily 0.1mL/10g body weight gavages;Negative control group is
Branched-chain amino acid(Leucine: isoleucine: valine in mass ratio 2:1:Obtain after 1 mixing)The aqueous solution, be made into dense
0.60g.kg-1.d-1, press 0.1mL/10g body weight gavages daily;Each group last is fed after 30min, carries out rat heavy burden
(5% body weight)Swimming test to power exhausts(Power exhausts standard:Heavy burden rats'swimming action is substantially lacked of proper care, it is impossible to is adhered to again or is sunk to
The bottom is unable to backwater surface and exhausts for power more than 3s).
(2) serum urea nitrogen test:Sample powder is taken, with distillation water dissolves, the concentration of sample is respectively
0.15g.kg-1.d-1、 0.30g.kg-1.d-1 、0.60g.kg-1.d-1 , sample sets press daily 0.1mL/10g body weight gavages;It is negative
Control group is branched-chain amino acid(Leucine: isoleucine: valine in mass ratio 2:1:Obtain after 1 mixing)The aqueous solution, match somebody with somebody
Into dense 0.60g.kg-1.d-1, press 0.1mL/10g body weight gavages daily;Each group is continuously fed after 30d, carries out rats'swimming examination
Test(Without heavy burden), after 90min, eyeball blood sampling is pulled out, use determination of urea nitrogen kit(Diacetyl hydrazine monoxime method, Beijing Chemical Plant's life
Produce)Detection serum urea nitrogen.
Result of the test
Embodiment sample is shown in Table 7 with impact of the control group to rat walking weight load.
Impact contrast of the embodiment sample of table 7 with control group to rat walking weight load
Note:Statistical analysis is carried out using variance analysis method, is compared with negative control group, " a ": p<0.05;With positive controls
Relatively, " b ": p<0.01 .
The embodiment sample of table 8 and impact of the control group to serum urea nitrogen content after rat motor
Note:Statistical analysis is carried out using variance analysis method, is compared with negative control group, " a ": p<0.05;With positive controls
Relatively, " b ": p<0.01 .
It is obvious to a person skilled in the art that the invention is not restricted to the details of above-mentioned one exemplary embodiment, Er Qie
In the case of spirit or essential attributes without departing substantially from the present invention, the present invention can be in other specific forms realized.Therefore, no matter
From the point of view of which point, embodiment all should be regarded as exemplary, and be nonrestrictive, the scope of the present invention is by appended power
Profit is required rather than described above is limited, it is intended that all in the implication and scope of the equivalency of claim by falling
Change is included in the present invention.
Moreover, it will be appreciated that although this specification is been described by according to embodiment, not each embodiment is only wrapped
Containing an independent technical scheme, this narrating mode of specification is only that for clarity those skilled in the art should
Using specification as an entirety, the technical scheme in each embodiment can also Jing it is appropriately combined, form those skilled in the art
Understandable other embodiment.The ins and outs of all not detailed descriptions in the present invention, can be appointed by this area
One prior art is realized.
Claims (7)
1. a kind of children's drinks, it is characterised in that in parts by weight, composed of the following components:Active component A 40-50,
Potassium chloride 1-3, xylitol 5-8, sodium citrate 2-4, white granulated sugar 10-30, active component B 11-15, active component C 9-13,
Dibastic sodium phosphate 2-6, Hami melon essence 0.3-0.5, glucan 3-5, water 105-135.
2. a kind of children's drinks according to claim 1, it is characterised in that in parts by weight, by following components group
Into:Active component A 43, potassium chloride 2, xylitol 6, sodium citrate 3, white granulated sugar 14, active component B 13, active component C
11, dibastic sodium phosphate 4, Hami melon essence 0.4, bextran 45, water 118.
3. a kind of children's drinks according to claim 1, it is characterised in that the active component A is long tail anchovy
Enzymolysis product, the preparation method of the long tail anchovy enzymolysis product is:S1. long tail anchovy minced fillet is taken, makes material-water ratio be 1:2-1:8(w/
V), solution ph is adjusted into 2.0-3.5 so that stomach acid or alkali environment is presented with 2 mol/L hydrochloric acid, is with enzyme-to-substrate concentration ratio
1200-1500U/g adds pepsin, and 37 DEG C, 100-130 r/min vibration enzymolysis are kept in thermostatic control oscillator vibration
1.5-2.5 h, obtain with this understanding the head product of Jing pepsins enzymolysis;S2. with the NaOH of 2 mol/L by Jing stomach eggs
Enzymolysis liquid pH value after white enzyme enzymolysis is adjusted to 8.0-9.0, keeps 37 DEG C of hydrolysis temperatures, and complex enzyme addition is 4500-6000
U/g, trypsase and the mass ratio of chymotrypsin are 4 in the complex enzyme:1-6:1, the material-water ratio 1:3-1:6, enzyme
The solution time is 3-4.5 h, and after enzymolysis terminates, go out enzyme 10min in 100 DEG C of boiling water baths;Enzymolysis product in S2 is passed through into vacuum
Freeze-drying, setting drying condition is -30 DEG C of precooling temperature, and pre-coo time 2h, heating-up temperature starts slow after 18h from -10 DEG C
Heat up, reach 25 DEG C, and remain to and be dried terminal, obtain long tail anchovy enzymolysis product.
4. a kind of children's drinks according to claim 3, it is characterised in that the active component A is long tail anchovy enzyme
Product is solved, the preparation method of the long tail anchovy enzymolysis product is:S1. long tail anchovy minced fillet is taken, makes material-water ratio be 1:3 (w/v), use 2
Solution ph is adjusted to 2.5 so that stomach acid or alkali environment is presented by mol/L hydrochloric acid, and by 1300 U/g of enzyme-to-substrate concentration ratio stomach is added
Protease, keeps 37 DEG C, 110 r/min vibration 2 h of enzymolysis in thermostatic control oscillator vibration, and Jing stomach eggs are obtained with this understanding
The head product of white enzyme enzymolysis;S2. the enzymolysis liquid pH value Jing after pepsin enzymolysis is adjusted into 8.5 with the NaOH of 2 mol/L,
Keep 37 DEG C of hydrolysis temperatures, complex enzyme addition be 5200 U/g, trypsase and chymotrypsin in the complex enzyme
Mass ratio be 5:1, the material-water ratio 1:4.5, enzymolysis time is 3.5 h, and after enzymolysis terminates, go out enzyme in 100 DEG C of boiling water baths
10min;By the enzymolysis product in S2 by vacuum freeze drying, settings drying condition is -30 DEG C of precooling temperature, pre-coo time
2h, heating-up temperature starts slowly to be heated up after 18h from -10 DEG C, reaches 25 DEG C, and remains to and be dried terminal, obtains long tail anchovy enzymolysis
Product.
5. a kind of children's drinks according to claim 1, it is characterised in that active component B is mud blood clam enzymolysis
Product, the preparation method of the mud blood clam enzymolysis product is:S1. take mud blood clam whole viscera and blend into meat gruel, make material-water ratio be 1:1-1:2
(w/v), solution ph is adjusted into 2.0 so that stomach acid or alkali environment is presented with 2 mol/L hydrochloric acid, with enzyme-to-substrate concentration ratio as 800-
1000U/g adds pepsin, and 37 DEG C, 75-105 r/min vibration enzymolysis 1-1.5 h are kept in thermostatic control oscillator vibration,
The head product of Jing pepsins enzymolysis is obtained with this understanding;S2. with the NaOH of 2 mol/L by Jing after pepsin enzymolysis
Enzymolysis liquid pH value be adjusted to 8.0-9.0, keep 37 DEG C of hydrolysis temperatures, complex enzyme addition is 2500-3500 U/g, described multiple
Trypsase and the mass ratio of chymotrypsin are 6 in synthase:1-8:1, the material-water ratio 1:2-1:4, enzymolysis time is
2.5-3.5 h, after enzymolysis terminates, go out enzyme 10min in 100 DEG C of boiling water baths;By the enzymolysis product in S2 by spray drying
Mode, setting drying condition is 160 DEG C of EAT, and sample introduction speed is 50ml/min, and centrifugal atomizer rotating speed is 25000r/
Min, obtains mud blood clam enzymolysis product.
6. a kind of children's drinks according to claim 5, it is characterised in that active component B is mud blood clam enzymolysis
Product, the preparation method of the mud blood clam enzymolysis product is:S1. take mud blood clam whole viscera and blend into meat gruel, make material-water ratio be 1:1.5
(w/v), solution ph is adjusted into 2.0 so that stomach acid or alkali environment is presented with 2 mol/L hydrochloric acid, is with enzyme-to-substrate concentration ratio
880U/g adds pepsin, 37 DEG C, 85 r/min vibration 1.3 h of enzymolysis is kept in thermostatic control oscillator vibration, in this condition
The head product of lower acquisition Jing pepsins enzymolysis;S2. with the NaOH of 2 mol/L by the enzymolysis liquid Jing after pepsin enzymolysis
PH value is adjusted to 8.2, keeps 37 DEG C of hydrolysis temperatures, and complex enzyme addition is 2900 U/g, in the complex enzyme trypsase with
The mass ratio of chymotrypsin is 7:1, the material-water ratio 1:2.5, enzymolysis time is 2.8 h, after enzymolysis terminates, at 100 DEG C
Go out enzyme 10min in boiling water bath;By the enzymolysis product in S2 by way of being spray-dried, setting drying condition is EAT
160 DEG C, sample introduction speed is 50ml/min, and centrifugal atomizer rotating speed is 25000r/min, obtains mud blood clam enzymolysis product.
7. a kind of children's drinks according to claim 1, it is characterised in that active component C is Asiatic plantain bacterium
Body crude extract, the preparation method of the Asiatic plantain thalline crude extract is:Root, stem, the leaf for taking fresh plant is cleaned respectively to not having
Significantly impurity, after surface sterilization is processed, is seeded to PDA(Separate endogenetic fungus)With Gause I culture medium(Life in separating is put
Line bacterium)Upper culture 5-7 d, are then peeled off obtaining bacterium colony;Picking inoculated by hypha block is in equipped with 100 mL from activated inclined plane
In the conical flask of ferment culture medium, 30 DEG C are put, the d of 150 r/min shaking tables shaken cultivation 3;Fermentation culture medium removes thalline, filtrate
Extracted 3 times with equal-volume ethyl acetate, merge organic phase, 45 DEG C of reduced pressure concentrations are evaporated, as mixed bacteria liquid crude extract;From
The heart and the thalline being filtrated to get, with appropriate 95% ethanol condensing reflux 3 times, merge ethanol phase, and reduced pressure concentration is evaporated, as bacterium
Body crude extract.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610788381.3A CN106616139A (en) | 2016-08-31 | 2016-08-31 | Children's functional drink |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610788381.3A CN106616139A (en) | 2016-08-31 | 2016-08-31 | Children's functional drink |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106616139A true CN106616139A (en) | 2017-05-10 |
Family
ID=58852995
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610788381.3A Pending CN106616139A (en) | 2016-08-31 | 2016-08-31 | Children's functional drink |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106616139A (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107668448A (en) * | 2017-10-26 | 2018-02-09 | 邓志程 | Suitable for the plant beverage of sub-health population |
CN107668449A (en) * | 2017-10-26 | 2018-02-09 | 邓志程 | A kind of health drink |
CN107691922A (en) * | 2017-10-26 | 2018-02-16 | 邓志程 | A kind of functional drink |
CN107751693A (en) * | 2017-10-26 | 2018-03-06 | 邓志程 | A kind of health beverages |
CN107889988A (en) * | 2017-10-26 | 2018-04-10 | 邓志程 | A kind of functional beverage |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101233937A (en) * | 2008-02-04 | 2008-08-06 | 江南大学 | Method for preparing loach selenium-rich active peptide nutrient solution or nutrition powder |
CN102266046A (en) * | 2010-06-04 | 2011-12-07 | 殷成军 | Preparation technology of loach oral liquid |
CN103070442A (en) * | 2012-08-09 | 2013-05-01 | 浙江省海洋开发研究院 | Pneumatophorus japonicns polypeptide function beverage and preparation process thereof |
CN103610195A (en) * | 2013-11-22 | 2014-03-05 | 蔡建中 | Making method for crocodile meat enzymolysis extracting solution |
CN104250616A (en) * | 2014-09-03 | 2014-12-31 | 中国热带农业科学院热带生物技术研究所 | Separation method for plant endophyte |
CN104757684A (en) * | 2015-04-30 | 2015-07-08 | 武汉大学 | Fish extract beverage production method |
-
2016
- 2016-08-31 CN CN201610788381.3A patent/CN106616139A/en active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101233937A (en) * | 2008-02-04 | 2008-08-06 | 江南大学 | Method for preparing loach selenium-rich active peptide nutrient solution or nutrition powder |
CN102266046A (en) * | 2010-06-04 | 2011-12-07 | 殷成军 | Preparation technology of loach oral liquid |
CN103070442A (en) * | 2012-08-09 | 2013-05-01 | 浙江省海洋开发研究院 | Pneumatophorus japonicns polypeptide function beverage and preparation process thereof |
CN103610195A (en) * | 2013-11-22 | 2014-03-05 | 蔡建中 | Making method for crocodile meat enzymolysis extracting solution |
CN104250616A (en) * | 2014-09-03 | 2014-12-31 | 中国热带农业科学院热带生物技术研究所 | Separation method for plant endophyte |
CN104757684A (en) * | 2015-04-30 | 2015-07-08 | 武汉大学 | Fish extract beverage production method |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107668448A (en) * | 2017-10-26 | 2018-02-09 | 邓志程 | Suitable for the plant beverage of sub-health population |
CN107668449A (en) * | 2017-10-26 | 2018-02-09 | 邓志程 | A kind of health drink |
CN107691922A (en) * | 2017-10-26 | 2018-02-16 | 邓志程 | A kind of functional drink |
CN107751693A (en) * | 2017-10-26 | 2018-03-06 | 邓志程 | A kind of health beverages |
CN107889988A (en) * | 2017-10-26 | 2018-04-10 | 邓志程 | A kind of functional beverage |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106616139A (en) | Children's functional drink | |
CN109071599A (en) | A kind of oligomeric Gly-His-Lys of walnut and its preparation method and application | |
CN104041903B (en) | A kind of rich selenium blue or green money willow drink and preparation method thereof | |
CN103190630B (en) | A kind of functional protein powder containing conjugated linoleic acid glyceride | |
CN101574151A (en) | Nutritional food with function of strengthening immunity and preparation method thereof | |
CN103082294A (en) | Application of bacteroides fragilis in preparation of composition for treating diarrhea | |
CN104921238A (en) | Toxin-removing and beauty-maintaining health-care beverage and preparation method thereof | |
CN106361842A (en) | Anti-fatigue healthcare capsules | |
CN103843890A (en) | Botanic milk lactobacillus beverage | |
CN106389478A (en) | Applications of Bacteroides fragilis in treatment and/or prevention of obesity or diabetes mellitus | |
CN102119939B (en) | Angiosperm bee pollen water extract for treating fatty liver and preparation method and application thereof | |
CN104017715A (en) | Passion fruit vinegar and preparation method thereof | |
CN106418067A (en) | Health beverage capable of replenishing physical power and relieving fatigue | |
CN104288344A (en) | Applications of a Pu'er tea extract product in preparation of medicines or foods adjusting intestinal flora and relaxing the bowels | |
CN106465862A (en) | A kind of nourishing healthy ocean milk | |
CN108477438A (en) | A kind of special alcohol-decomposing beverage and preparation method thereof of hyperuricemia and patient with gout | |
CN107177638A (en) | The highly enriched fermentation process and its active product of Yunnan olive polyphenol | |
CN106620658A (en) | Nutritious skin whitening healthcare product | |
CN103098873A (en) | Peanut and red date sour milk beverage | |
CN102948733B (en) | Production method and formula of special-eating life nutrition liquid | |
CN104189038A (en) | Traditional Chinese medicine preparation for regulating female physical health and immunity | |
CN111067108A (en) | Rose tartary buckwheat polypeptide oral liquid and preparation method thereof | |
CN104585444A (en) | Plant herbal-tea beverage containing taurine | |
CN102599398B (en) | Kidney tonifying and lung-heat cleaning garden stuff nutrition congee | |
CN104013853B (en) | A kind of composition of strong kidney kidney tonifying and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170510 |